Scientists hunt for blood test to predict dangerous pregnancy conditions
NCT ID NCT01490489
Summary
This study aimed to find a better way to predict serious pregnancy complications like pre-eclampsia and poor fetal growth. Researchers tested whether measuring a specific protein (EG-VEGF) in a pregnant person's blood between 14-18 weeks could serve as an early warning sign. The goal was to identify at-risk pregnancies earlier to allow for closer monitoring and management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-ECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical investigation center of the Grenoble University Hospital
Grenoble, Isere, 38043, France
Conditions
Explore the condition pages connected to this study.